Overexpression of insulin-like growth factor II following transarterial chemoembolization may be associated with rapid progression of hepatocellular carcinoma.

被引：0
|
作者：
Song, BC [1 ]
Chung, YH [1 ]
Yang, SH [1 ]
Kim, JA [1 ]
Choi, WB [1 ]
Lee, SS [1 ]
Jung, SA [1 ]
Yoon, HK [1 ]
Sung, KB [1 ]
Lee, HC [1 ]
Lee, YS [1 ]
Suh, DJ [1 ]
机构：
[1] Univ Ulsan, Coll Med, Asan Med Ctr, Seoul, South Korea
来源：
HEPATOLOGY | 1999年 / 30卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
2080
引用
收藏
页码：680A / 680A
页数：1
相关论文
共 50 条
  • [1] Upregulation of insulin-like growth factor II may be associated with metastasis of hepatocellular carcinoma following transarterial chemoembolization
    Song, BC
    Chung, YH
    Park, MI
    Yang, SH
    Kim, JA
    Hong, IR
    Choi, WB
    Lee, SS
    Jung, SA
    Yoon, HK
    Sung, KB
    Lee, YS
    Suh, DJ
    JOURNAL OF HEPATOLOGY, 2000, 32 : 164 - 164
  • [2] Prognostic significance of serum insulin-like growth factor-1 in patients with hepatocellular carcinoma following transarterial chemoembolization
    Liu, Sheng
    Liu, Yanhua
    Jiang, Xuewen
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2016, 11 (02) : 607 - 612
  • [3] Differential expression of insulin-like growth factor II mRNA in hepatocellular carcinoma.
    Ng, IOL
    Lee, JMF
    Srivastava, G
    GASTROENTEROLOGY, 1996, 110 (04) : A1277 - A1277
  • [4] Insulin-like growth factor II in hepatocellular carcinoma
    Jeng, Jeng-Eing
    Chuang, Lea-Yea
    Chuang, Wang-Lung
    Chang, Jan-Gowth
    Tsai, Jung-Fa
    BIOMARKERS IN MEDICINE, 2007, 1 (02) : 261 - 271
  • [5] Serum Insulin-Like Growth Factor-1 Predicts Disease Progression and Survival in Patients with Hepatocellular Carcinoma Who Undergo Transarterial Chemoembolization
    Cho, Eunju
    Kim, Hyo-Cheol
    Lee, Jeong-Hoon
    Yoo, Jeong-ju
    Choi, Won-Mook
    Cho, Young Youn
    Lee, Min Jong
    Cho, Yuri
    Lee, Dong Hyeon
    Lee, Yun Bin
    Yu, Su Jong
    Kim, Yoon Jun
    Yoon, Jung-Hwan
    Chung, Jin Wook
    Kim, Chung Yong
    Lee, Hyo-Suk
    PLOS ONE, 2014, 9 (03):
  • [6] SERUM INSULIN-LIKE GROWTH FACTOR-1 PREDICTS DISEASE PROGRESSION AND SURVIVAL IN PATIENTS WITH HEPATOCELLULAR CARCINOMA WHO UNDERGO TRANSARTERIAL CHEMOEMBOLIZATION
    Cho, E. J.
    Kim, H. -C.
    Lee, J. -H.
    Yoo, J. -J.
    Cho, Y.
    Lee, D. H.
    Lee, Y. B.
    Yu, S. J.
    Kim, Y. J.
    Yoon, J. -H.
    Chung, J. W.
    Lee, H. -S.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S404 - S404
  • [7] Expression and prognostic significance of insulin-like growth factor-2 receptor in human hepatocellular carcinoma and the influence of transarterial chemoembolization
    Lautem, Anja
    Simon, Frank
    Hoppe-Lotichius, Maria
    Mittler, Jens
    Vollmar, Johanna
    Schad, Arno
    Dueber, Christoph
    Galle, Peter Robert
    Otto, Gerd
    Zimmermann, Tim
    Lang, Hauke
    ONCOLOGY REPORTS, 2019, 41 (04) : 2299 - 2310
  • [8] Comparison of expression of insulin-like growth factor II and alpha-fetoprotein genes in hepatocellular carcinoma.
    Ng, IOL
    Lee, JMF
    Srivastava, G
    Ng, M
    HEPATOLOGY, 1996, 24 (04) : 1710 - 1710
  • [9] Somatic overgrowth associated with overexpression of insulin-like growth factor II
    Morison, IM
    Becroft, DM
    Taniguchi, T
    Woods, CG
    Reeve, AE
    NATURE MEDICINE, 1996, 2 (03) : 311 - 316
  • [10] Expression of insulin-like growth factor II mRNA in hepatocellular carcinoma
    Ng, IO
    Lee, JMF
    Srivastava, G
    Ng, M
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1998, 13 (02) : 152 - 157
12345